BSOFT

- Birlasoft Limited has announced the appointment of Madhavan Hariharan as Chief Executive Officer and Managing Director, effective December 8, 2026. - He succeeds Angan Guha, who led the company through its previous phase of evolution. - Madhavan Hariharan brings extensive experience from his prior leadership roles within the CKA Birla Group, including serving as Group CFO.

- Mr. Angan Guha has resigned as Director, CEO, and Managing Director of Birlasoft Limited due to personal reasons, effective December 7, 2026. - Mr. Madhavan Hariharan has been appointed as Additional Director and designated as CEO and Managing Director for a period of 2 years, effective December 8, 2026.

Current scenario: - Delivered sequential revenue growth of 2.1% in constant currency and dollar terms, and 2.7% in rupee terms. - Deal signings for Q2 came in at $116.1 million TCV (up 9% YoY) and for H1 at $285 million (up 15% YoY). - EBITDA margin for the quarter was 15.2%, impacted by organization-wide wage hikes effective July 2026. Changes in trends: - E&U vertical witnessed softness due to a client ramp-down in Europe; no immediate bounce-back expected. - Offshore intensity continues to rise, driven by higher delivery efficiencies and advanced AI services. - Support staff costs rationalized while sales and capability-building investments increased. Management Guidance & Outlook: - Confident that H2 financial performance will be better than H1, assuming no unforeseen macro shocks or client surprises. - Q3 will see typical seasonal softness due to furloughs. - Focus remains heavily on driving sales pipelines, improving deal velocity, and expanding the order book for FY28 growth. Capex: - Reinvesting in physical and technical infrastructure and office refurbishments, leading to higher depreciation and amortization costs. Growth Drivers: - Advanced AI, Generative AI, and Agentic AI capabilities (including AWS AI Services Competency and OpenAI partnership) driving client conversations and win rates. - Strong traction in Manufacturing, BFSI, and Life Sciences verticals.